TBIOTelesis Bio Inc.

Nasdaq codexdna.com


$ 3.39 $ 0.06 (1.79 %)    

Thursday, 29-Aug-2024 15:58:03 EDT
QQQ $ 465.64 $ -8.04 (-1.7 %)
DIA $ 411.86 $ -2.33 (-0.56 %)
SPY $ 555.78 $ -5.05 (-0.9 %)
TLT $ 97.57 $ 0.52 (0.54 %)
GLD $ 229.81 $ -0.49 (-0.21 %)
$ 3.42
$ 3.48 x 100
-- x --
-- - --
$ 3.03 - $ 25.20
42,537
na
6.06M
$ 0.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 03-29-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-11-2023 06-30-2023 10-Q
6 05-12-2023 03-31-2023 10-Q
7 03-22-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-09-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-23-2022 12-31-2021 10-K
12 11-10-2021 09-30-2021 10-Q
13 08-11-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 telesis-bio-q2-adj-762-misses-403-estimate-sales-155m-miss-650m-estimate

Telesis Bio (NASDAQ:TBIO) reported quarterly losses of $(7.62) per share which missed the analyst consensus estimate of $(4.03)...

 telesis-bio-shares-resume-trade
Telesis Bio Shares Resume Trade
07/31/2024 15:37:35

 telesis-bio-q1-2024-adj-eps-552-misses-023-estimate-sales-3440m-miss-6900m-estimate

Telesis Bio (NASDAQ:TBIO) reported quarterly losses of $(5.52) per share which missed the analyst consensus estimate of $(0.23)...

 telesis-bio-announces-1-for-18-reverse-stock-split-will-open-for-trading-on-the-nasdaq-global-select-market-on-may-9-2024-on-a-post-split-basis

Telesis Bio Inc. (the Company) (NASDAQ:TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate th...

 telesis-bio-inc-announces-strategic-focus-on-game-changing-gibson-sola-enzymatic-dna-synthesis-platform-and-bioxp-mrna-solutions--todd-r-nelson-to-step-down-as-ceo-eric-esser-president-and-coo-of-telesis-bio-will-assume-the-role-of-the-cos-cep-effective-immediately

Telesis Bio Inc. (NASDAQ:TBIO), a leader in automated benchtop DNA and mRNA synthesis solutions, today announced a focus in str...

 telesis-bio-q4-eps-061-misses-022-estimate-sales-698m-miss-700m-estimate

Telesis Bio (NASDAQ:TBIO) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.22)...

 why-cardlytics-shares-are-trading-higher-by-around-37-here-are-20-stocks-moving-premarket

Shares of Cardlytics, Inc. (NASDAQ: CDLX) rose sharply in today’s pre-market trading after the company reported better-than-ex...

 why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION